AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -64.7% | 7,428 | 0.0% | 0.00% | – |
| Q4 2021 | $17,000 | -19.0% | 7,428 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -25.0% | 7,428 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | +12.0% | 7,428 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +19.0% | 7,428 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | +10.5% | 7,428 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | -81.0% | 7,428 | 0.0% | 0.00% | – |
| Q2 2020 | $100,000 | +194.1% | 7,428 | +66.3% | 0.00% | – |
| Q1 2020 | $34,000 | +21.4% | 4,466 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -31.7% | 4,466 | -46.9% | 0.00% | – |
| Q2 2019 | $41,000 | -40.6% | 8,418 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | +53.3% | 8,418 | 0.0% | 0.00% | – |
| Q4 2018 | $45,000 | +9.8% | 8,418 | +80.1% | 0.00% | – |
| Q3 2018 | $41,000 | -12.8% | 4,675 | 0.0% | 0.00% | – |
| Q2 2018 | $47,000 | +4.4% | 4,675 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | -34.8% | 4,675 | 0.0% | 0.00% | – |
| Q4 2017 | $69,000 | – | 4,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |